Document is current
Any future updates will be listed below
-
Authors
Hong, Eun-Gyoung https://orcid.org/0000-0003-3390-5706
Min, Kyung-Wan https://orcid.org/0000-0003-2266-9795
Lim, Jung Soo https://orcid.org/0000-0003-4856-3462
Ahn, Kyu-Jeung https://orcid.org/0000-0002-4648-3605
Ahn, Chul Woo https://orcid.org/0000-0003-3733-7486
Yu, Jae-Myung https://orcid.org/0000-0001-9179-1554
Kim, Hye Soon https://orcid.org/0000-0001-6298-3506
Kim, Hyun Jin https://orcid.org/0000-0002-6760-4963
Kim, Won https://orcid.org/0000-0003-4067-8767
Kim, Dong Han https://orcid.org/0000-0002-4507-2038
Jang, Hak Chul https://orcid.org/0000-0002-4188-6536
-
Funding
Funding for this research was provided by:
Sanofi Korea
Seoul National University
- License Information
-
More Information
Article History
Received: 2 February 2024
Accepted: 23 February 2024
First Online: 21 March 2024
Declarations
:
: Won Kim and Dong Han Kim are employees of Sanofi Korea. Eun-Gyoung Hong, Kyung-Wan Min, Jung Soo Lim, Kyu-Jeung Ahn, Chul Woo Ahn, Hye Soon Kim, Hyun Jin Kim, and Hak Chul Jang declare no competing interests.
: The study was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines and was approved by the institutional review board at each of the 27 study sites (see Supplementary Materials Table ), starting from first approval at Kyung Hee University Hospital at Gangdong Institutional Review Board (Approval code KHNMC 2016-05-005, Approval date 2016–05-20). All participants provided written, informed consent prior to enrollment and for anonymized patient information to be published in this article.
